Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Monthly budget adjustments keep your finances on track. Learn how small tweaks help you respond to income changes and shifting priorities.
27,140 articlesA leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Federal prosecutors dismantle a sprawling fraud machine that used mass texting, scripted pitches, and fake crypto pla...
Oil jolts can rattle markets fast. This guide explains why oil spikes matter for stocks, what history shows, and acti...
Facing a slide in Micron's stock, investors wonder: why is micron stock still falling? This guide breaks down the mem...
When a tech chief sells shares, investors take notice. This deep-dive explains what InterDigital's CTO's sale could m...
Solar’s most hated year is fading into a powerful five-month rally. The Invesco SOLAR ETF has surged roughly 45% sinc...
Opendoor's CEO recently bought 100,000 shares, signaling confidence to shareholders. This article breaks down what t...
Dogecoin's slump continues with another dip, underscoring the volatility of meme coins. This guide breaks down why th...
A look at the CEO's statements and what they mean for marvell stock investors amazing. Learn actionable steps, risk f...
Markets swing between fear and opportunity. This guide shows how to identify a growth stock dynamo before a breakout,...
President Trump orders a tight 24-day sprint for Senate approval of the CLARITY Act, aiming to restore U.S. leadershi...
Latin America's fintech leaders have faced a choppy earnings season, but patient investors see potential. This guide ...